Ignyta Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters??? Option To Purchase Additional Shares Post author:Sam Post published:May 9, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like FDA Orders 6 Partial or Full Clinical Holds on Celgene's Blood Cancer Studies September 6, 2017 Innate Tanked as Drug Combined With Bristol-Myers' Opdivo Flopped in Study November 26, 2017 Aptinyx Bags $70M Financing to Fuel Expanding Pipeline December 17, 2017